|
|
|
|
LEADER |
02758nam a2200565Ia 4500 |
001 |
10.1002-acp.3448 |
008 |
220706s2018 CNT 000 0 und d |
020 |
|
|
|a 08884080 (ISSN)
|
245 |
1 |
0 |
|a Effects of probabilities, adverse outcomes, and status quo on perceived riskiness of medications: Testing explanatory hypotheses concerning gist, worry, and numeracy
|
260 |
|
0 |
|b John Wiley and Sons Ltd
|c 2018
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1002/acp.3448
|
520 |
3 |
|
|a We tested predictions of fuzzy-trace theory that qualitative health status and gist representations (ordinal and categorical) of risks contribute to willingness to start medications, beyond effects of objective risk, emotion (worry), and numeracy. Adults in two experiments were given hypothetical scenarios based on actual medications, varying health status quo (acceptable or unacceptable), adverse event (pneumonia or cancer), and four levels of quantitative risk (from 1/100,000 to 1/100) between subjects. In both experiments, cancer and higher quantitative risk elicited greater worry and risk perceptions and reduced willingness to start a new medication. Willingness to start was also influenced by health status quo. After controlling for other variables, only status quo and gist representations consistently predicted willingness to start in both experiments. Results support an integrated approach to understanding and predicting perceptions of the risks of medications that encompasses numerical cognition, emotions (such as worry), and qualitative gist representations of medical information. © 2018 John Wiley & Sons, Ltd.
|
650 |
0 |
4 |
|a adult
|
650 |
0 |
4 |
|a adverse outcome
|
650 |
0 |
4 |
|a Article
|
650 |
0 |
4 |
|a cognition
|
650 |
0 |
4 |
|a controlled study
|
650 |
0 |
4 |
|a emotion
|
650 |
0 |
4 |
|a female
|
650 |
0 |
4 |
|a fuzzy trace theory
|
650 |
0 |
4 |
|a fuzzy-trace theory
|
650 |
0 |
4 |
|a gist
|
650 |
0 |
4 |
|a health status
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a hypothesis
|
650 |
0 |
4 |
|a male
|
650 |
0 |
4 |
|a malignant neoplasm
|
650 |
0 |
4 |
|a medical information
|
650 |
0 |
4 |
|a medication compliance
|
650 |
0 |
4 |
|a numeracy
|
650 |
0 |
4 |
|a patient attitude
|
650 |
0 |
4 |
|a patient risk
|
650 |
0 |
4 |
|a patient worry
|
650 |
0 |
4 |
|a perception
|
650 |
0 |
4 |
|a pneumonia
|
650 |
0 |
4 |
|a prediction
|
650 |
0 |
4 |
|a priority journal
|
650 |
0 |
4 |
|a probability
|
650 |
0 |
4 |
|a qualitative analysis
|
650 |
0 |
4 |
|a qualitative research
|
650 |
0 |
4 |
|a quantitative analysis
|
650 |
0 |
4 |
|a risk assessment
|
650 |
0 |
4 |
|a risk communication
|
650 |
0 |
4 |
|a risk factor
|
650 |
0 |
4 |
|a side effects
|
650 |
0 |
4 |
|a theory
|
700 |
1 |
|
|a Fraenkel, L.
|e author
|
700 |
1 |
|
|a Reyna, V.F.
|e author
|
700 |
1 |
|
|a Wilhelms, E.A.
|e author
|
773 |
|
|
|t Applied Cognitive Psychology
|